CONMED Corp (CNMD) Latest Filing Signal

Latest Filing: 10-K  |  Filed Feb 17, 2026

Cross-checked across multiple AI analysts and grounded in the latest SEC filing.

powered by: earningsVibe.ai

Question:
What is the latest filing signal for CONMED Corp?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, CONMED Corp's filing signal turned negative.
earningsVibe SuperAnalyst™ Verdict: TURNED NEGATIVE

Signal Performance — Stock Price Since Filing

30-Day Change
-13.51%
from filing date
60-Day Change
Pending
from filing date

Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT

PERPLEXITY
Continuing Negative
GEMINI
Turned Negative
CLAUDE
Turned Negative
CHATGPT
Continuing Positive

Unlock the Full Filing Analysis

See full earningsSig™ and risksSig™ analysis across 5,000+ companies

Get Started Free →

No credit card required

Question:
What does CONMED Corp actually do?
Answer:
CONMED Corporation is a medical technology company that designs, manufactures, and distributes devices and equipment for surgical procedures, primarily in orthopedics and general surgery. With approximately 3,900 employees and three primary manufacturing locations, the company serves surgeons and healthcare professionals globally across specialties like sports medicine, general surgery, gynecology, and gastroenterology. CONMED's strategy focuses on organic growth through new product introductions and enhancements, leveraging differentiated products, and optimizing its portfolio via strategic acquisitions and distribution agreements. The company emphasizes quality, technological excellence, and customer service, with most facilities certified under ISO international quality standards. Approximately 86% of its revenue is derived from recurring single-use products, complemented by capital equipment sales.
Question:
What are CONMED Corp's revenue drivers?
Answer:
Revenue is primarily driven by the sale of single-use products within its orthopedic and general surgery segments, which constitute approximately 86% of total revenue. Capital equipment sales also contribute, facilitating ongoing sales of related single-use products and accessories.

Cut through noisy SEC filings to find the signal faster

Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.

Get Started Free →

No credit card required